Charles Glabe

37.2k citations
195 papers · 28.4k · 12 hit papers · h-index 85

Impact in

  • Physiology top 0.01%
    • Alzheimer's disease research and treatments
  • Neurology top 0.1%
    • Neuroinflammation and Neurodegeneration Mechanisms

Papers in

    • Alzheimer's disease research and treatments 122
    • Prion Diseases and Protein Misfolding 36
    • Amyloidosis: Diagnosis, Treatment, Outcomes 19
    • Protein Structure and Dynamics 13

Charles Glabe

193 papers receiving 27.9k citations

Charles Glabe's Hit Papers

Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril 2016 · 687 citations
6870+11+23Years since publication10002.0k3.0k

Peers

Charles Glabe
Comparison fields: 5 of 155
  • Physiology 18.6k
  • Neurology 3.1k
  • Biological Psychiatry 766
  • Pharmacology 3.8k
  • Cellular and Molecular Neuroscience 4.0k
Replace Rakez Kayed with:
Rakez Kayed United States
David B. Teplow United States
William L. Klein United States
Eckhard Mandelkow� Germany
Konrad Beyreuther Germany
Gerd Multhaup Germany
Bruce A. Yankner United States
Brian J. Bacskai United States
Todd E. Golde United States
David Schubert United States
Charles Glabe relative to Rakez Kayed United States Rakez Kayed's profile →
Citations per field
00.5×1.5×
Rakez Kayed · 1×
Citations per year

Countries citing papers authored by Charles Glabe

Since Specialization
Citations

This map shows the geographic impact of Charles Glabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Glabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Glabe more than expected).

Fields of papers citing papers by Charles Glabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Glabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Glabe. The network helps show where Charles Glabe may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles Glabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles Glabe Line = papers co-authored together Charles Glabe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
Hit paper breakdown →
20033415
2
Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo
Hit paper breakdown →
20041918
3
Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦
Hit paper breakdown →
2005856
4
Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases
Hit paper breakdown →
2004755
5
In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity
Hit paper breakdown →
1991741
6
Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril
Hit paper breakdown →
2016687
7
Structural Classification of Toxic Amyloid Oligomers
Hit paper breakdown →
2008660
8
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Hit paper breakdown →
1999644
9
Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers
Hit paper breakdown →
2007639
10
Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity
Hit paper breakdown →
1995625
11
Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct
Hit paper breakdown →
2007582
12
Atomic View of a Toxic Amyloid Small Oligomer
Hit paper breakdown →
2012494
13 2006482
14 2006420
15 2013371
16 2012345
17 2002334
18 2005321
19 2006290
20 1994283

About Charles Glabe

Charles Glabe is a scholar working on Physiology, Molecular Biology, Cellular and Molecular Neuroscience, Computational Theory and Mathematics and Neurology, having authored 195 papers that have together received 28.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (122 papers), Prion Diseases and Protein Misfolding (36 papers), Computational Drug Discovery Methods (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Neuroscience and Neuropharmacology Research (15 papers), Protein Structure and Dynamics (13 papers) and Supramolecular Self-Assembly in Materials (13 papers). The work is most often cited by research in Physiology (18.6k citations), Neurology (3.1k citations), Biological Psychiatry (766 citations), Pharmacology (3.8k citations) and Cellular and Molecular Neuroscience (4.0k citations). Charles Glabe has collaborated with scholars based in United States, Saudi Arabia and Japan. Frequent co-authors include Rakez Kayed, Saskia Milton, Carl W. Cotman, Elizabeth Head, Theresa M. McIntire, Jennifer L. Thompson, Christian J. Pike, Erene Mina, Joseph V. Kosmoski and Mihaela Necula. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of Neuroscience, The Journal of Cell Biology and Developmental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact